Company news
Alembic Limited (NSE:ALEMBICLTD) news
Alembic Limited news releases on 6ix. Latest, Jul 4, 2025: Alembic : Annual Report 2024-25
Press releases & updates
Alembic : Annual Report 2024-25
July 4, 2025
Trade Spotlight: How should you trade Alembic, Huhtamaki, Delhivery, Voltas, Aarti Industries, and others on Tuesday?
August 19, 2024
Alembic Pharmaceuticals announces USFDA Dabigatran Etexilate Capsules, 110 mg
August 14, 2024
Alembic Pharmaceuticals announces USFDA Final Approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg
July 25, 2024
HFT Scan : Aarti Pharmalabs and Alembic Limited in focus
May 14, 2024
Alembic Pharmaceuticals - Revenue up 18% to Rs. 1486 crores in Q-1 FY24
August 7, 2023
Alembic : Annual Report 2022-23
July 12, 2023
Alembic : Audited Financial Results for the Quarter and Financial year ended 31st March, 2023
May 11, 2023
Alembic : AL-Extract-Consolidated Financial Result-IE-Eng-12.05.2023
May 11, 2023
Alembic : AL-Extract-Consolidated Financial Result-FE-Guj-12.05.2023
May 11, 2023
Alembic Pharmaceuticals receives USFDA Final Approval for Cyclophosphamide Capsules 25 mg and 50 mg
November 14, 2022
Alembic Pharmaceuticals announces its first injectable product approval from its General Sterile Facility Final Approval for Glycopyrrolate Injection USP
November 2, 2022
Alembic Pharmaceuticals receives USFDA Final Approval for Paclitaxel Injection USP, 30 mg/5 mL, 100 mg/16.7 mL, and 300 mg/50 mL Multiple-Dose Vials.
October 28, 2022
Alembic Pharmaceuticals receives USFDA Final Approval for Chlorthalidone Tablets USP, 25 mg and 50 mg.
August 30, 2022
Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%
August 9, 2022
Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Diclofenac Sodium Topical Gel, 3%
August 1, 2022
Alembic Pharmaceuticals receives USFDA Final Approval for Pirfenidone Tablets, 267 mg a~d 801 mg
May 25, 2022
Alembic Pharmaceuticals announces USFDA Tentative Approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg
April 8, 2022
Alembic : Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Final Approval for Metronidazole Gel USP. 1%
September 7, 2021
Alembic : Pharmaceuticals announces USFDA Final Approval for Desipramine Hydrochloride Tablets USP, 10 mg. 25 mg. 50 mg, 75 mg, 100 mg, and 150 mg
July 9, 2021
Alembic : Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Tentative Approval for Metronidazole Gel USP, 1%.
May 5, 2021
Alembic : Pharmaceuticals announces its wholly-owned subsidiary, Alembic Global Holding SA receives USFDA Final Approval for Treprostinil Injection
February 15, 2021